Comparing Neupogen vs Releuko
| Neupogen (filgrastim) | Releuko (filgrastim) |
|
|---|
| Neupogen (filgrastim) | Releuko (filgrastim) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Bone Marrow Transplantation. Releuko may also be used for purposes not listed in this medication guide. |
Related suggestions Neutropenia Associated with Chemotherapy
Neutropenia
Bone Marrow Transplantation
Popular comparisons
|
|||||||
| More about Neupogen (filgrastim) | More about Releuko (filgrastim) | ||||||||
| Ratings & Reviews | |||||||||
|
Neupogen has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Neupogen side effects |
View all Releuko side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Releuko prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Other filgrastim brands include: Nivestym, Nypozi, Releuko, Zarxio | Other filgrastim brands include: Neupogen, Nivestym, Nypozi, Zarxio | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
5.8 hours |
5.8 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 176 drugs are known to interact with Neupogen:
|
A total of 176 drugs are known to interact with Releuko:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
February 20, 1991 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.